Clinical Trials
7 trialsNCT07379047 2026-04-24
GISTAR-1
Ningbo Newbay Technology Development Co., Ltd
Phase 2/3 Not yet recruiting
NCT02106858 2023-07-24
StivargaPMS
Bayer
Completed
NCT03465722 2022-10-06
(VOYAGER) Study of Avapritinib vs Regorafenib in Patients With Locally Advanced Unresectable or Metastatic GIST
Blueprint Medicines Corporation
Phase 3 Completed
NCT01933958 2022-04-01
Regorafenib Post-marketing Surveillance in Japan
Bayer
Completed
NCT01271712 2021-01-29
GRID
Bayer
Phase 3 Completed
NCT01689376 2016-08-16
Regorafenib in Subjects With Gastrointestinal Stromal Tumors (GIST) Who Have Progressed After Standard Therapy (Managed Access Program)
Bayer
No longer available
NCT01646593 2014-12-15
Regorafenib in Subjects With Gastrointestinal Stromal Tumors (GIST) Who Have Progressed After Standard Therapy
Bayer
No longer available